Skip to content
Assyro AI

Title f-27 LAWS reference

Explore the full hierarchy of this title across chapters, subchapters, and parts.

Select a part from the tree to begin

Browse chapters and parts on the left to load sections

CANADA • Title f-27 Laws • Part 13

Part 13 — Therapeutic product authorizations

This section clarifies that the definition of 'therapeutic product authorization' applies to all relevant authorizations, including active and suspended licences, issued prior to the section's effective date. These authorizations cover a wide range of activities related to therapeutic products, such as import, sale, manufacture, and testing.

What this part covers

  • The definition of 'therapeutic product authorization' (as per subsection 2(3)) applies to authorizations issued before the section's coming into force.
  • This includes both active licences and suspended authorizations or licences.
  • These authorizations cover activities such as import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage, or testing of a therapeutic product.

Sections in Part 13

§ 13

Therapeutic product authorizations

Regulatory Context

This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.

CANADALaws

Related Terms

Operational Use Cases

Related Actions